Technology Development of Image-Guided Interventions: Phase I (R21)
The summary for the Technology Development of Image-Guided Interventions: Phase I (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Technology Development of Image-Guided Interventions: Phase I (R21): -This funding opportunity announcement (FOA) solicits Exploratory-Developmental (R21) grant applications from applicant organizations that propose to develop high-impact, disruptive technologies for image-guided interventions. As defined here, image-guided interventions (IGI) integrate treatment with imaging technologies at the point of patient care. The long-term goal of the IGI initiative is to produce disruptive technologies that will replace current treatments with minimally invasive, image-guided interventions. A disruptive technology is a new technological innovation that displaces the existing dominant technology. Examples of disruptive technologies include minimally invasive, image-guided procedures that replace invasive surgery or low-cost image-guided interventions. -This FOA is intended to support the first phase of a two-phase project that will deliver high clinical impact, image-guided interventions. Multidisciplinary collaborations and partnerships with industry are encouraged. In addition, development of multi-potential technologies that might have applicability across a range of clinical conditions is also encouraged.
| Federal Grant Title: | Technology Development of Image-Guided Interventions: Phase I (R21) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-EB-06-003 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.28693.394 |
| CFDA Descriptions: | Discovery and Applied Research for Technological Innovations to Improve Human Health 93.394 Cancer Detection and Diagnosis Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Oct 24, 2006 |
| Posted Date: | Aug 24, 2006 |
| Creation Date: | Aug 24, 2006 |
| Archive Date: | Nov 23, 2006 |
| Total Program Funding: | $5,000,000 |
| Maximum Federal Grant Award: | $300,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.395 -- Cancer Treatment Research |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Special district governments Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Research proposals that do not include both imaging AND an intervention will be considered non-responsive to this Program and will not be peer reviewed. Proposals must identify a clinical problem (or problems) that will potentially be addressed by the project. Proposals describing incremental technology advances will be considered non-responsive and will not be peer reviewed. The focus of the work must be on the development of the technology or methods NOT on the utilization or testing of the method in humans. Applications focusing on utilization or testing will be considered non-responsive and will not be peer reviewed. A one page or less, general outline for Phase II must be included in the research plan. Applications that do not outline Phase II in the research plan will be considered non-responsive and will not be peer reviewed. Applications must include a detailed plan for software sharing, as described in Section V, 2.D. The expectation is that the code developed as part of the proposed research will be shared freely. Applications that do not include either a software dissemination plan or the justification for that lack of such a plan will not be peer reviewed. Proposed components of IGI systems must be designed with open architecture and incorporate a non-proprietary interface to other systems. Applications should include a plan describing the interoperability of hardware and software. Applications that do not describe a plan for interoperability and the use of open architecture or provide justification for their use of a proprietary interface will be considered non-responsive and will not be peer reviewed. Applicants may submit more than one application, provided each application is scientifically distinct.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster